Advanced in Prostate Cancer

Friedemann Zengerling

Albert Einstein Allee 23, 
Ulm, BW, DE 
Advanced in Prostate Cancer
Albert Einstein Allee 23, 
Ulm, BW, DE 
OverviewLocationsClinical Research

Overview

Friedemann Zengerling practices in Ulm, Germany. Zengerling is rated as an Advanced expert by MediFind in the treatment of Prostate Cancer. Their top areas of expertise are Testicular Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Their clinical research consists of co-authoring 118 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 23 articles and participated in 1 clinical trial in the study of Prostate Cancer.

Locations

Albert Einstein Allee 23, Ulm, BW 89081, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
Carboplatin Chemotherapy and Involved Node Radiotherapy in Stage IIA/B Seminoma
Carboplatin Chemotherapy and Involved Node Radiotherapy in Stage IIA/B Seminoma
Enrollment Status: Terminated
Publish Date: February 13, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 2
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma. A Multicenter, Open Label Phase II Trial With Two Cohorts
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma. A Multicenter, Open Label Phase II Trial With Two Cohorts
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug
Study Drugs: Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 2
View 2 Less Clinical Trials

118 Total Publications

First clinical application of silicon-based [¹⁸F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.
First clinical application of silicon-based [¹⁸F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.
Journal: Nuklearmedizin. Nuclear medicine
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zengerling's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile